Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer (Q81996205)
Jump to navigation
Jump to search
scientific article published on 01 September 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer |
scientific article published on 01 September 2008 |
Statements
Induction of immune responses and clinical efficacy in a phase II trial of IDM-2101, a 10-epitope cytotoxic T-lymphocyte vaccine, in metastatic non-small-cell lung cancer (English)
Minal Barve
James Bender
Neil Senzer
Casey Cunningham
F Anthony Greco
David McCune
Ronald Steis
Hung Khong
Donald Richards
Joe Stephenson
Prasanthi Ganesa
Jackie Nemunaitis
Glenn Ishioka
Beena Pappen
Michael Nemunaitis
Michael Morse
Bonnie Mills
Phillip B Maples
Jeffrey Sherman
John J Nemunaitis
1 September 2008